Cargando…
Klotho: A new therapeutic target in diabetic retinopathy?
Klotho (Kl) is considered an antiaging gene, mainly for the inhibition of the insulin-like growth factor-1 signaling. Kl exists as full-length transmembrane, which acts as co-receptor for fibroblast growth factor receptor, and in soluble forms (sKl). The sKl may exert pleiotropic effects on organs a...
Autores principales: | Puddu, Alessandra, Maggi, Davide Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401458/ https://www.ncbi.nlm.nih.gov/pubmed/37547589 http://dx.doi.org/10.4239/wjd.v14.i7.1027 |
Ejemplares similares
-
Diabetes more than retinopathy, it’s effect on the anterior segment of eye
por: Morya, Arvind Kumar, et al.
Publicado: (2023) -
The complexity of integrins in cancer and new scopes for therapeutic targeting
por: Hamidi, Hellyeh, et al.
Publicado: (2016) -
Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022) -
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
por: Nagy, Geza, et al.
Publicado: (2022) -
Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases
por: Kim, Won Kyu, et al.
Publicado: (2023)